IP Library Granted Patent US 8,889,710
Granted Patent B2
US 8,889,710 · App. 14/137,279 · Granted Nov 18, 2014

Parasiticidal dihydroisoxazole compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,889,710
App. No.
14/137,279
Granted
Nov 18, 2014
Kind
B2
Abstract

Provided are dihydroisoxazole compounds I useful for controlling parasites both in animals and agriculture. Further provided are methods for controlling parasite infestations of an animal by administering an effective amount of a compound as described above, or a pharmaceutically acceptable salt thereof, to an animal, as well as formulations for controlling parasite infestations using the compounds described above or an acceptable salt thereof, and an acceptable carrier. Also provided are compounds and processes useful for making the dihydroisoxazole compounds. wherein A is

Claims (51)

1. A compound, or a salt thereof, of formula I

wherein A is

n is 0 or 1;

R 1 is phenyl substituted with 2 or 3 of the same or different halo atoms;

R 2 is, at each occurrence, hydrogen;

R 3 is

p is, at each occurrence, independently 0 or 1;

R 4 is

R 5 is

 and

R 6 is hydrogen, C 1 -C 5 haloalkyl, C 1 -C 5 cyanoalkyl, or C 2 -C 5 alkynyl.

2. The compound of claim 1 , or salt thereof, wherein

R 1 is phenyl substituted 3 times with the same or different of chloro and fluoro;

n is 0;

R 3 is —CH 2 —R 4 ;

R 4 is —C(O)—R 5 ;

and R 6 is difluoroethyl, cyanomethyl, or ethylmethyl.

3. The compound of claim 2 or salt thereof, wherein R 1 is

4. The compound of claim 3 or salt thereof, wherein R 3 is

5. The compound of claim 3 or salt thereof, wherein R 3 is

6. The compound of claim 3 or salt thereof, wherein R 3 is

7. The compound of claim 1 , or salt thereof, being 3-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxo-2-(prop-2-ynylamino)ethyl)-5,6-dihydro-4H-cyclopenta[c]thiophene-1-carboxamide.

8. The compound of claim 1 , or salt thereof, being (S)-3-(5-(3,5-dichloro-4-fluorophenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-(2-oxo-2-(prop-2-ynylamino)ethyl)-5,6-dihydro-4H-cyclopenta[c]thiophene-1-carboxamide.

9. A formulation comprising a compound of claim 1 , or a salt thereof, and one or more acceptable carriers.

10. A formulation comprising a compound of claim 2 , or a salt thereof, and one or more acceptable carriers.

11. The formulation of claim 10 , further comprising an additional active ingredient.

12. The formulation of claim 11 , wherein the formulation is an injectable formulation.

13. A formulation comprising a compound of claim 4 , or a salt thereof, and one or more acceptable carriers.

14. The formulation of claim 13 further comprising an additional active ingredient.

15. The formulation of claim 14 , wherein the formulation is an injectable formulation.

16. A formulation comprising a compound of claim 6 , or a salt thereof, and one or more acceptable carriers.

17. The formulation of claim 16 , further comprising an additional active ingredient.

18. The formulation of claim 17 , wherein the formulation is an injectable formulation.

19. A formulation comprising a compound of claim 8 , or a salt thereof, and one or more acceptable carriers.

20. The formulation of claim 19 , further comprising an additional active ingredient.

21. The formulation of claim 20 , wherein the formulation is an injectable formulation.

22. A method of controlling a parasite infestation in or on a non-human mammal in need thereof comprising administering an effective amount of a compound of claim 1 , or salt thereof, to said animal.

23. The method of claim 22 , wherein said non-human mammal is a dog or cat, and said parasite is a flea or tick.

24. The method of claim 23 , wherein the administering is parenteral administration.

25. A method of controlling a parasite infestation in or on a non-human mammal in need thereof comprising administering an effective amount of a compound of claim 2 , or salt thereof, to said animal.

26. The method of claim 25 , wherein said non-human mammal is a dog or cat, and said parasite is a flea or tick.

27. The method of claim 26 , wherein the administering is parenteral administration.

28. A method of controlling a parasite infestation in or on a non-human mammal in need thereof comprising administering an effective amount of a compound of claim 4 , or salt thereof, to said animal.

29. The method of claim 28 , wherein said non-human mammal is a dog or cat, and said parasite is a flea or tick.

30. The method of claim 29 , wherein the administering is parenteral administration.

31. A method of controlling a parasite infestation in or on a non-human mammal in need thereof comprising administering an effective amount of a compound of claim 6 , or salt thereof, to said animal.

32. The method of claim 31 , wherein said non-human mammal is a dog or cat, and said parasite is a flea or tick.

33. The method of claim 32 , wherein the administering is parenteral administration.

34. A method of controlling a parasite infestation in or on a non-human mammal in need thereof comprising administering an effective amount of a compound of claim 8 , or salt thereof, to said animal.

35. The method of claim 34 , wherein said non-human mammal is a dog or cat, and said parasite is a flea or tick.

36. The method of claim 35 , wherein the administering is parenteral administration.

Assignments (3)
ASSIGNMENT OF SECURITY INTEREST IN PATENT RIGHTS, RECORDED ON AUGUST 3, 2020, AT REEL/FRAME 053388/0967 Recorded Dec 3, 2025
From: GOLDMAN SACHS BANK USA, AS RETIRING COLLATERAL AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR COLLATERAL AGENT
Reel/Frame 073816/0021 →
SECURITY INTEREST Recorded Aug 3, 2020
From: ELANCO US INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 053388/0967 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: ELI LILLY AND COMPANY
To: ELANCO US INC.
Reel/Frame 044701/0447 →